One study from 2012 looking at a high‐risk acute myeloid leukemia (AML) cohort showed a 49% 2‐year event‐free survival for isolated del(5q) with absent del(17p), but did not assess TP53 mutations.16 Here, TP53 is linked to acute myeloid leukemia.